70. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Skandinavischen Gesellschaft für Neurochirurgie
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
12.05. - 15.05.2019, Würzburg
ePoster Montag, 13.05.2019
Neurochirurgische Onkologie III/Neurosurgical oncology III
Meeting Abstract
(P071)
[Volltext]
The role of the calpain/calpastatin system in chemoresistance of glioblastoma
Hannen R, Chen Cy, Schilling O, Bartsch JW, Nimsky C[Volltext]
Meeting Abstract
(P072)
[Volltext]
Decision for extent of surgical resection in elderly glioblastoma
Ahmadipour Y, Müller O, Dammann P, Pierscianek D, Darkwah Oppong M, Grzywotz A, Sure U, Jabbarli R[Volltext]
Meeting Abstract
(P073)
[Volltext]
The expression of the intercellular communication proteins GAP43 and Cx43 in diffuse and anaplastic gliomas
Krigers A, Moser P, Fritsch H, Thomé C, Freyschlag CF[Volltext]
Meeting Abstract
(P074)
[Volltext]
The synthetic ligand Apelin-F13A binds and activates glioblastoma APLNR reducing the pro-invasive side effect of anti-angiogenic therapy
Kälin R, Stöcklein V, Li M, Reinhard S, Mastrella G, Wagner E, Tonn JC, Glass R[Volltext]
Meeting Abstract
(P075)
[Volltext]
Early clinical experience with gliovac (ERC1671) antitumor vaccination therapy for recurrent glioblastoma
Heiland T, Karpel-Massler G, Wirtz CR, Halatsch ME[Volltext]
Meeting Abstract
(P076)
[Volltext]
Current evidence for the application of blood-based biomarkers in high grade gliomas
Pierscianek D, Ahmadipour Y, Darkwah Oppong M, Rauschenbach L, Michel A, Sure U, Jabbarli R[Volltext]
Meeting Abstract
(P077)
[Volltext]
Microenvironmental release of CHI3L1 drives transcriptional re-programming and promotes proliferation
Wurm J, Behringer S, Franco P, Beck J, Schnell O, Heiland DH[Volltext]
Meeting Abstract
(P078)
[Volltext]
Extracellular released glutamate stimulates a proliferative-autocrine-loop in glioblastoma
Garrelfs N, Behringer S, Wurm J, Beck J, Schnell O, Heiland DH[Volltext]
Meeting Abstract
(P079)
[Volltext]
Effects of protocadherin gamma C3 (PCDHGC3) knockout on proliferation, invasion and self-renewal abilities in glioblastoma cell lines
Kempe CD, Baptista F, Fabregat MC, Li N, Hagemann C, Burek M[Volltext]
Meeting Abstract
(P080)
[Volltext]
Pro-invasive side effects of bevacizumab and ramucirumab therapy in proneural and classical GBM is mediated by apelin signalling and reducible by apelin receptor blockade
Stöcklein V, Li M, Harter PN, Zdouc N, Mittelbronn M, Tonn JC, Glass R, Kälin R[Volltext]
Meeting Abstract
(P081)
[Volltext]
Meningeosis neoplastica in patients with high-grade gliomas
Sachkova A, Komboz F, Petrov A, Bock HC, Mielke D, Rohde V, Malinova V[Volltext]
Meeting Abstract
(P082)
[Volltext]
Interim results from a proof-of-concept clinical trial assessing the safety of the coordinated undermining of survival paths by 9 repurposed drugs (version 3) combined with metronomic temozolomide (CUSP9v3) protocol for recurrent glioblastoma
Halatsch ME, Kast RE, Karpel-Massler G, Schmitz B, Zolk O, Bullinger L, Mayer-Steinacker R, Maier L, Scheuerle A, Mayer B, Schmidt C, Zeiler K, Elshaer Z, Awad F, Panther P, Schmelzle B, Beckers K, Siegelin MD, Westhoff MA, Wirtz CR, Bouche G, Heiland T[Volltext]
